End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30,750 KRW | +1.15% | +6.03% | -23.60% |
2023 | Invex Therapeutics, Peptron End Collaboration, Manufacturing Deal | MT |
2023 | Tranche Update on Peptron, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Sales 2022 | 5.81B 4.25M | Sales 2023 | 3.34B 2.44M | Capitalization | 830B 607M |
---|---|---|---|---|---|
Net income 2022 | -15.06B -11.01M | Net income 2023 | -15.92B -11.64M | EV / Sales 2022 | 25.8 x |
Net cash position 2022 | 8.02B 5.86M | Net Debt 2023 | 4.15B 3.03M | EV / Sales 2023 | 250 x |
P/E ratio 2022 |
-10.5
x | P/E ratio 2023 |
-52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.67% |
1 day | +1.15% | ||
1 week | +6.03% | ||
Current month | +6.03% | ||
1 month | +22.02% | ||
3 months | +34.57% | ||
6 months | -6.82% | ||
Current year | -23.60% |
Managers | Title | Age | Since |
---|---|---|---|
Min-Ho Song
CEO | Chief Executive Officer | 63 | 21-03-29 |
Ho-Il Choi
CEO | Chief Executive Officer | 58 | 97-11-20 |
Seung-Gu Jang
DFI | Director of Finance/CFO | 58 | 99-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ho-Il Choi
CEO | Chief Executive Officer | 58 | 97-11-20 |
Seung-Gu Jang
DFI | Director of Finance/CFO | 58 | 99-06-30 |
Young-Go Jung
BRD | Director/Board Member | 49 | 14-03-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 30,750 | +1.15% | 381,506 |
24-05-07 | 30,400 | -0.65% | 215,303 |
24-05-03 | 30,600 | +0.99% | 666,430 |
24-05-02 | 30,300 | +4.48% | 945,600 |
24-04-30 | 29,000 | +2.65% | 379,654 |
End-of-day quote Korea S.E., May 07, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-23.60% | 462M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- A087010 Stock